As of Feb. 24, Medi-Cal Rx PA requirements reinstated for 46 Standard Therapeutic Classes

Provider Icon

As of Feb. 24, 2023, prior authorization (PA) requirements have been reinstated for 46 additional Standard Therapeutic Classes (STCs) for beneficiaries 22 and older (Phase II, Wave 2).

For full details, please review the Jan. 24 notification from DHCS. You can also keep up to date on Medi-Cal reinstatement on the Medi-Cal Rx Education and Outreach webpage.

Phase II, Wave 2 Drug Classes
Adrenergics B Complex with Vitamin C Laxatives
All Other Antiobesity Preps Bile Therapy Mineralocorticoids
Allergens Bronchodilators Oxytocics
Amphetamine Preparations Chloramphenicol Parasympathetic Agents
Anesthetics Gen Inhalant CNS Stimulants Psychostimulants- Antidepressant
Anesthetics Gen Inject Coal Tar Rauwolfias
Anticonvulsants Cold and Cough Preparations Sedative Barbiturate
Antidiarrheals Contraceptives, Non-Systemic Sedative Non-Barbiturate
Antidotes Cough Preparations/Expectorants Trimethoprim
Antihistamines Diagnostics Vaginal Cleansers
Antinauseants Digestants Vasodilators Peripheral
Antineoplastics Emetics Xanthine Derivatives
Antipruritics Enzymes Medical Supplies *
Antispasmodic and Anticholinergic Agents Hematinics and Blood Cell Stimulators Miscellaneous **
Antithyroid Preps Hemorrhoidal Preparations
Ataractics-Tranquilizers Hemostatics

Additional resources

You can attend a Medi-Cal Rx Reinstatement Webinar every Friday at noon or watch a recording of the webinar at your convenience.

Important upcoming dates

  • March 24, 2023: DHCS will begin to lift transition policies that were in place for beneficiaries ages 22 years and older (Phase III).


Call the Medi-Cal Rx Customer Service Center at 800-977-2273 (available 24/7) days a week or email Medi-Cal Rx Education & Outreach at [email protected].